These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34334612)

  • 41. Accuracy of an electrochemical sensor for measuring capillary blood ketones by fingerstick samples during metabolic deterioration after continuous subcutaneous insulin infusion interruption in type 1 diabetic patients.
    Guerci B; Benichou M; Floriot M; Bohme P; Fougnot S; Franck P; Drouin P
    Diabetes Care; 2003 Apr; 26(4):1137-41. PubMed ID: 12663586
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Euglycemic ketosis in patients with type 2 diabetes on SGLT2-inhibitor therapy-an emerging problem and solutions offered by diabetes technology.
    Pfützner A; Klonoff D; Heinemann L; Ejskjaer N; Pickup J
    Endocrine; 2017 Apr; 56(1):212-216. PubMed ID: 28303514
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lack of lipotoxicity effect on {beta}-cell dysfunction in ketosis-prone type 2 diabetes.
    Umpierrez GE; Smiley D; Robalino G; Peng L; Gosmanov AR; Kitabchi AE
    Diabetes Care; 2010 Mar; 33(3):626-31. PubMed ID: 20028938
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessment of the "Second Day" Exercise Effect on Glycemic Control, Insulin Requirements, and CHO Intake in Type 1 Diabetes Adults.
    Müller-Korbsch M; Frühwald L; Heer M; Fangmeyer-Binder M; Reinhart-Mikocki D; Fasching P
    J Diabetes Sci Technol; 2021 Jan; 15(1):127-133. PubMed ID: 31583900
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of capillary ketones monitoring in treatment of mild ketotic crisis in people with ketosis-prone atypical diabetes.
    Sobngwi E; Ngo Ngai CGG; Etoga ME; Lontchi-Yimagou E; Mbanya A; Dehayem M; Mbanya JC
    J Investig Med; 2020 Aug; 68(6):1193-1195. PubMed ID: 32665366
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Measurement of β-hydroxybutyrate in cats with nonketotic diabetes mellitus, diabetic ketosis, and diabetic ketoacidosis.
    Weingart C; Lotz F; Kohn B
    J Vet Diagn Invest; 2012 Mar; 24(2):295-300. PubMed ID: 22362525
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Exogenous Ketone Supplementation and Keto-Adaptation for Endurance Performance: Disentangling the Effects of Two Distinct Metabolic States.
    Shaw DM; Merien F; Braakhuis A; Maunder E; Dulson DK
    Sports Med; 2020 Apr; 50(4):641-656. PubMed ID: 31820376
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Substrate metabolism, hormone and cytokine levels and adipose tissue signalling in individuals with type 1 diabetes after insulin withdrawal and subsequent insulin therapy to model the initiating steps of ketoacidosis.
    Voss TS; Vendelbo MH; Kampmann U; Pedersen SB; Nielsen TS; Johannsen M; Svart MV; Jessen N; Møller N
    Diabetologia; 2019 Mar; 62(3):494-503. PubMed ID: 30506451
    [TBL] [Abstract][Full Text] [Related]  

  • 49. POSTPRANDIAL DOSING OF BOLUS INSULIN IN PATIENTS WITH TYPE 1 DIABETES: A CROSS-SECTIONAL STUDY USING DATA FROM THE T1D EXCHANGE REGISTRY.
    Peters A; Van Name MA; Thorsted BL; Piltoft JS; Tamborlane WV
    Endocr Pract; 2017 Oct; 23(10):1201-1209. PubMed ID: 28704103
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review.
    Matsuda E; Brennan P
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-10. PubMed ID: 27820140
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Managing blood glucose during and after exercise in Type 1 diabetes: reproducibility of glucose response and a trial of a structured algorithm adjusting insulin and carbohydrate intake.
    Kilbride L; Charlton J; Aitken G; Hill GW; Davison RC; McKnight JA
    J Clin Nurs; 2011 Dec; 20(23-24):3423-9. PubMed ID: 21884557
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Beyond type 2 diabetes: sodium glucose co-transporter-inhibition in type 1 diabetes.
    Biester T; Kordonouri O; Danne T
    Diabetes Obes Metab; 2019 Apr; 21 Suppl 2():53-61. PubMed ID: 31081591
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence, Cost, and Burden of Diabetic Ketoacidosis.
    Virdi N; Poon Y; Abaniel R; Bergenstal RM
    Diabetes Technol Ther; 2023 Jun; 25(S3):S75-S84. PubMed ID: 37306442
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The clinical and hormonal (C-peptide and glucagon) profile and liability to ketoacidosis during nutritional rehabilitation in Ethiopian patients with malnutrition-related diabetes mellitus.
    Abdulkadir J; Mengesha B; Welde Gebriel Z; Keen H; Worku Y; Gebre P; Bekele A; Urga K; Taddesse AS
    Diabetologia; 1990 Apr; 33(4):222-7. PubMed ID: 2112100
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk of ketosis during intensive insulin therapy in pre-school-age diabetic children.
    Brambilla P; Artavia-Loria E; Chaussain JL; Bougneres PF
    Diabetes Care; 1987; 10(1):44-8. PubMed ID: 3105985
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metabolic Effects of an SGLT2 Inhibitor (Dapagliflozin) During a Period of Acute Insulin Withdrawal and Development of Ketoacidosis in People With Type 1 Diabetes.
    Herring RA; Shojaee-Moradie F; Garesse R; Stevenage M; Jackson N; Fielding BA; Mendis A; Johnsen S; Umpleby AM; Davies M; Russell-Jones DL
    Diabetes Care; 2020 Sep; 43(9):2128-2136. PubMed ID: 32641376
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A cluster randomised trial, cost-effectiveness analysis and psychosocial evaluation of insulin pump therapy compared with multiple injections during flexible intensive insulin therapy for type 1 diabetes: the REPOSE Trial.
    Heller S; White D; Lee E; Lawton J; Pollard D; Waugh N; Amiel S; Barnard K; Beckwith A; Brennan A; Campbell M; Cooper C; Dimairo M; Dixon S; Elliott J; Evans M; Green F; Hackney G; Hammond P; Hallowell N; Jaap A; Kennon B; Kirkham J; Lindsay R; Mansell P; Papaioannou D; Rankin D; Royle P; Smithson WH; Taylor C
    Health Technol Assess; 2017 Apr; 21(20):1-278. PubMed ID: 28440211
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Turnover and splanchnic metabolism of free fatty acids and ketones in insulin-dependent diabetics at rest and in response to exercise.
    Wahren J; Sato Y; Ostman J; Hagenfeldt L; Felig P
    J Clin Invest; 1984 May; 73(5):1367-76. PubMed ID: 6715541
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sick-day management in type 1 diabetes.
    Laffel L
    Endocrinol Metab Clin North Am; 2000 Dec; 29(4):707-23. PubMed ID: 11149158
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The use of nutritional supplements to induce ketosis and reduce symptoms associated with keto-induction: a narrative review.
    Harvey CJDC; Schofield GM; Williden M
    PeerJ; 2018; 6():e4488. PubMed ID: 29576959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.